Instem Stock

Instem Liabilities

Delisted·Nov 20, 2023

The The Liabilities of Instem (INS.L) as of Aug 10, 2026 is 39.35 M GBP. In the previous year, The Liabilities was 43.88 M GBP — a change of -10.32% (lower).

Liabilities

39.35 MGBP

YoY

-10.32%

Last updated:

In 2026, Instem's total liabilities amounted to 39.35 M GBP, a -10.32% difference from the 43.88 M GBP total liabilities in the previous year.

Access this data via the Eulerpool API

Instem Stock analysis

What does Instem do? Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Instem's Liabilities

Instem's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Instem's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Instem's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Instem's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Instem’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Instem stock

The Liabilities of Instem is 39.35 M GBP in 2026.

The Liabilities of Instem changed from 43.88 M GBP to 39.35 M GBP, representing a -10.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Instem since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Instem historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Instem

All Key Metrics — Instem